Skip to main content
Log in

Corticosteroids and bone

  • Round Table Discussion
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Schaadt O, Boler H (1978) Loss of bone mineral in axial and peripheral skeleton in aging, prednisone treatment and osteoporosis. In: Dequeker J, Johnston, C. C. Jr. (eds) Noninvasive bone measurements: methodological problems. IRL Press, Oxford and Washington, D.C., pp. 207–214

    Google Scholar 

  • Gennari C, Bernini M, Nardi P, Fusi L, Francini G, Nami R, Montagnani M, Imbimbo B, Avioli LV (1983) Glucocorticoids: radiocalcium and radiophosphate absorption in man. In: Dixon A St J., Russell RGG, Stamp TCB (eds) Osteoporosis: a multi-disciplinary problem. Academic Press and Grune and Stratton, London and New York, pp 75–80

    Google Scholar 

  • Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL (1977) Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 60:253–259

    CAS  PubMed  Google Scholar 

  • Hahn TJ, Halstead LR, Baran DT (1981) Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111–115

    CAS  PubMed  Google Scholar 

  • Reid DM, Kennedy NSJ, Smith MA, Tothill P, Nuki G (1982) Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J 285:330–332

    Article  CAS  Google Scholar 

  • Gluck OS, Murphy WA, Hahn TJ, Hahn BH (1981) Bone loss in adults receiving alternate day glucocorticoid therapy: a comparison with daily therapy. Arthritis Rheum 24:892–898

    CAS  PubMed  Google Scholar 

  • Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH (1979) Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J Clin Invest 64:655–665

    Article  CAS  PubMed  Google Scholar 

  • Fucik RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA (1975) Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 40:152–155

    Article  CAS  PubMed  Google Scholar 

  • Lo Cascio V, Adami S, Avioli LV, Cominacini L, Galvanini G, Gennari C, Imbimbo B, Scuro LA (1982) Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man. Calcif Tissue Int 34:309–310

    CAS  Google Scholar 

  • Suzuki Y, Ichikawa Y, Saito E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151–156

    Article  CAS  PubMed  Google Scholar 

  • Baxter JD (1978) Mechanisms of glucocorticoid inhibition of growth. Kidney Int 14:330–333

    CAS  PubMed  Google Scholar 

  • Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ (1979) Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303–311

    Article  Google Scholar 

  • Canalis E, (1983) Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112:931–939

    CAS  PubMed  Google Scholar 

  • Wong GL (1979) Basal activities and hormone responsiveness of osteoclast-like and osteoblast-like bone cells are regulated by glucocorticoids. J Biol Chem 254:6337–6340

    CAS  PubMed  Google Scholar 

  • Schiatti P, Selva D, Barone D, Restelli A, Glässer A (1980) Antiinflammatory activity and other pharmacological properties of 11β, 21-dihydroxy-2′-methyl-5′β H-pregna-1,4-dieno[17,16-d] oxazole-3,20-dione-21-acetate (deflazacort). Drug Res 30:1543–1549

    CAS  Google Scholar 

  • Buniva G, Dubini A, Sassella D (1979) Human bioassay of corticotropin-suppressing, eosinopenic and hyperglycaemic potencies of deflazacort and prednisone. Curr Therap Res 146:69–81

    Google Scholar 

  • Criscuolo D, Fraioli F, Bonifacio V, Paolucci D, Isidori A (1980) Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone. J CLin Pharmacol, Ther Toxicology 18:37–41

    CAS  Google Scholar 

  • Martinelli E, Ferrari P, Ripamonti A, Tuan G, Perazzi A, Assandri, A (1979) Metabolism of deflazacort in the rat, dog and man. Am Soc Pharm Exp Ther 7:335–339

    CAS  Google Scholar 

  • Hahn TJ, Halstead LR, Strates B, Imbimbo B, Baran DT (1980) Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man. Calcif Tissue Int 31:109–115

    CAS  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peck, W., Gennari, C., Raisz, L. et al. Corticosteroids and bone. Calcif Tissue Int 36, 4–7 (1984). https://doi.org/10.1007/BF02405286

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02405286

Keywords

Navigation